Beta Drugs Ltd. share price target

Name: Latest research reports of Beta Drugs Ltd. authored by Edelweiss and published by - Trendlyne research reports.
Item: Beta Drugs Ltd.
Rating: 5
Author: Edelweiss

Beta Drugs Ltd. has an average target of 2245. The consensus estimate represents an upside of 25.00% from the last price of 1795.95. View 2 reports from 1 analysts offering long-term price targets for Beta Drugs Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report
08 Nov 2024	Beta Drugs	Edelweiss Target	1795.95	2245.00	2194.00 (-18.14%)	Target met	Buy	pdf post cache
16 May 2024	Beta Drugs	Edelweiss Target	1795.95	1600.00	1179.90 (52.21%)	Target met	Buy	pdf post cache
03 Sep 2023	Beta Drugs	Edelweiss	1795.95	1325.00	999.95 (79.60%)	Target met	Buy	pdf post cache
24 Mar 2023	Beta Drugs	Edelweiss	1795.95		610.00 (194.42%)		Not Rated	pdf post cache

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

63.27% Gain from 52W Low

Beta Drugs Ltd. share price target

Beta Drugs Ltd. has an average target of 2245. The consensus estimate represents an upside of 25.00% from the last price of 1795.95. View 2 reports from 1 analysts offering long-term price targets for Beta Drugs Ltd..

Advisor Screeners